Phase II trial of oral β-all trans-retinoic acid in hepatocellular carcinoma (SWOG 9157)

Investigational New Drugs

Volumn 16, Issue 2, 1998, Pages 171-173

  Meyskens Jr , Frank L ^a   Jacobson, Joth ^b   Nguyen, Bichlien ^a   Weiss, Geoffrey R ^c   Gandara, David R ^d   MacDonald, John S ^e  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e TEMPLE UNIVERSITY   (United States)

Author keywords

Hepatocellular carcinoma; Hepatoma; Retinoic acid; Vitamin A

Indexed keywords

BILIRUBIN; CREATININE; RETINOIC ACID;

ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTHRALGIA; ARTICLE; BILIRUBIN BLOOD LEVEL; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; CREATININE BLOOD LEVEL; DIARRHEA; DRUG EFFICACY; DRY SKIN; FATIGUE; HEADACHE; HUMAN; HYPERCALCEMIA; LETHARGY; LIVER CELL CARCINOMA; LIVER FUNCTION TEST; MALAISE; MYALGIA; NAUSEA; ORAL DRUG ADMINISTRATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; STOMATITIS; SURVIVAL TIME; VOMITING;

ADMINISTRATION, ORAL; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; SURVIVAL RATE; TRETINOIN;

EID: 7844242539     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006032706362     Document Type: Article

References (10)

1. Meyskens FL: Recent advances in the management of cancer with retinoids. Annals of Oncology 5: 529-532, 1994
2. Warrell RP Jr.: Clinical and molecular aspects of retinoid therapy for acute promyelocytic leukemia. Int J Cancer 70: 496-497, 1997
3. Garcia M, de The H, Tiollais P, Samarut J, Dejean A: A Hepatitis virus pre-s-retinoic acid receptor beta chimera transforms erythrocytic progenitor cells in vitro. Proceed National Acad Science USA 90: 89-93, 1993
4. Sever C, Loeker J: Expression of retinoic acid and receptor genes in liver and hepacellular carcinoma. Mol Carcinogenesis 4: 138-144, 1991
5. Hsu SL, Lin HM, Chou CK: Suppression of the tumorgenicity of human hepatoma hep3B cells by long-term retinoic acid treatment. Cancer Letters 99: 79-85, 1996
6. Li C, Locker J, Wan YJ: RXR-mediated regulation of the alpha-fetoprotein gene through an upstream element. DNA and Cell Biology 15: 955-963, 1996
7. Harvey WH, Fleming TR, Goodman PJ, Hawkins JE, Macdonald JS: Phase II study of trimetrexate in previously untreated patients with hepatocellular carcinoma. Invest New Drags 11: 45-46, 1993
8. Poplin EA, Tangen CM, Harvey WH, Macdonald JS: Hepatoma/merbarone: a Southwest Oncology Group Study. Invest New Drugs 12: 337-340, 1994
9. Muto Y, Moriwake H, Ninomiya A et al.: Prevention of second primary tumors by an acyclic retinoid, polyprenoic acid, in patients with hepatocellular carcinoma. Hepatoma Prevention Study. New Eng of Med 334: 1561-1567, 1996
10. Nakamura N, Shidoji Y, Yamada Y, Hatakeyama H, Moriwaki H, Muto Y: Induction of apoptosis by acyclic retinoid in the human hepatoma-derive cell line, HuH-7. Biochem and Biophysic Res Comm 207: 382-388, 1995